I don't know if you agree with me, but I was really hoping that the results for P would be positive since from my perspective, this validates Menon's reported genius/understanding of trial design details and interpretation of preclinical to human trial results. Although the share price has not followed, I have increased confidence in this little gem because of the P results. I now fully anticipate that B-OM will be successful as well and that a partner will be announced for P relatively soon.